These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25870913)
21. 5-HT(2C) receptor agonists and the control of appetite. Halford JC; Harrold JA Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823 [TBL] [Abstract][Full Text] [Related]
22. A Positive Allosteric Modulator of the Serotonin 5-HT García-Cárceles J; Decara JM; Vázquez-Villa H; Rodríguez R; Codesido E; Cruces J; Brea J; Loza MI; Alén F; Botta J; McCormick PJ; Ballesteros JA; Benhamú B; Rodríguez de Fonseca F; López-Rodríguez ML J Med Chem; 2017 Dec; 60(23):9575-9584. PubMed ID: 29116785 [TBL] [Abstract][Full Text] [Related]
23. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272 [TBL] [Abstract][Full Text] [Related]
25. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809 [TBL] [Abstract][Full Text] [Related]
32. Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014). Yang Y; An S; Liu Y; Guo XX; Gao L; Wei JF; Xu TR Expert Opin Ther Pat; 2016; 26(1):89-106. PubMed ID: 26609882 [TBL] [Abstract][Full Text] [Related]
33. Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Bubar MJ; Cunningham KA Curr Top Med Chem; 2006; 6(18):1971-85. PubMed ID: 17017968 [TBL] [Abstract][Full Text] [Related]
34. Lorcaserin: a novel serotonin 2C agonist for the treatment of obesity. Nigro SC; Luon D; Baker WL Curr Med Res Opin; 2013 Jul; 29(7):839-48. PubMed ID: 23574263 [TBL] [Abstract][Full Text] [Related]
38. Serotonergic anti-obesity agents: past experience and future prospects. Halford JC; Boyland EJ; Lawton CL; Blundell JE; Harrold JA Drugs; 2011 Dec; 71(17):2247-55. PubMed ID: 22085383 [TBL] [Abstract][Full Text] [Related]
39. Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats. Fletcher PJ; Li Z; Ji X; Higgins GA; Funk D; Lê AD Neuropharmacology; 2022 Sep; 215():109150. PubMed ID: 35644487 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats. Gannon BM; Sulima A; Rice KC; Collins GT J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]